- Home
- IMNM vs TBLA Comparison
IMNM vs TBLA Comparison
Compare IMNM & TBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- TBLA
- Stock Information
- Founded
- IMNM 2006
- TBLA 2007
- Country
- IMNM United States
- TBLA United States
- Employees
- IMNM N/A
- TBLA N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- TBLA Computer Software: Programming Data Processing
- Sector
- IMNM Health Care
- TBLA Technology
- Exchange
- IMNM Nasdaq
- TBLA Nasdaq
- Market Cap
- IMNM 945.8M
- TBLA 991.0M
- IPO Year
- IMNM 2020
- TBLA N/A
- Fundamental
- Price
- IMNM $9.01
- TBLA $3.48
- Analyst Decision
- IMNM Strong Buy
- TBLA Strong Buy
- Analyst Count
- IMNM 8
- TBLA 5
- Target Price
- IMNM $24.75
- TBLA $4.50
- AVG Volume (30 Days)
- IMNM 1.0M
- TBLA 1.1M
- Earning Date
- IMNM 11-12-2025
- TBLA 11-06-2025
- Dividend Yield
- IMNM N/A
- TBLA N/A
- EPS Growth
- IMNM N/A
- TBLA N/A
- EPS
- IMNM N/A
- TBLA 0.04
- Revenue
- IMNM $12,589,000.00
- TBLA $1,817,019,000.00
- Revenue This Year
- IMNM N/A
- TBLA $8.20
- Revenue Next Year
- IMNM $154.73
- TBLA $4.60
- P/E Ratio
- IMNM N/A
- TBLA $82.85
- Revenue Growth
- IMNM 16.74
- TBLA 12.01
- 52 Week Low
- IMNM $5.15
- TBLA $2.50
- 52 Week High
- IMNM $16.73
- TBLA $4.30
- Technical
- Relative Strength Index (RSI)
- IMNM 43.25
- TBLA 60.17
- Support Level
- IMNM $9.01
- TBLA $3.28
- Resistance Level
- IMNM $9.63
- TBLA $3.45
- Average True Range (ATR)
- IMNM 0.71
- TBLA 0.08
- MACD
- IMNM -0.07
- TBLA 0.01
- Stochastic Oscillator
- IMNM 17.38
- TBLA 75.38
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About TBLA Taboola.com Ltd.
Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, United States, Germany, Rest of the world. It generates the majority of its revenue from the United States.